跳到主要内容
NEW: Oxford’s @OxfordVacGroup has launched the world’s first Phase I clinical trial of a vaccine against Bundibugyo ebolavirus, in response to the ongoing outbreak in the Democratic Republic of the Congo and neighbouring Uganda.
Find out more ⬇️